Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
UNIVERSIDADE FEDERAL DO RIO DE JANEIRO has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These matters are assigned to 2 distinct examiners, ensuring that each case is reviewed by a different individual. The portfolio is also distributed across 2 distinct art units, which indicates that the pending matters fall into different technical classifications within the biotechnology field. This distribution requires the company to navigate multiple sets of examination guidelines simultaneously.
The busiest examiner for the company is AULAKH, CHARANJIT, who is currently handling 1 pending office action. This 1 busiest examiner pending action is part of the total workload. Because the workload is split between the distinct examiners and art units, the company must manage separate prosecution tracks. This lack of concentration means that the outcome of the 2 pending office actions will depend on the unique requirements of the different examiners in the specialized units. Practitioners should prepare for varied feedback across these different filings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AULAKH, CHARANJIT | 1 | 80.7% | -14.5% |
| TAYLOR, JORDAN W | 1 | 63.2% | +36.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18294913 | N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS | AULAKH, CHARANJIT | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17916256 | CATALYST FOR THE GENERATION OF HYDROGEN AND/OR SYNTHESIS GAS, METHOD FOR OBTAINING SAME AND USE IN A STEAM REFORMING PROCESS | TAYLOR, JORDAN W | 12d |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1738 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18294913 | N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITS | AULAKH, CHARANJIT | 1621 | §103 | Final Rejection | — | Pending | Feb 02, 2024 |
| 17916256 | CATALYST FOR THE GENERATION OF HYDROGEN AND/OR SYNTHESIS GAS, METHOD FOR OBTAINING SAME AND USE IN A STEAM REFORMING PROCESS | TAYLOR, JORDAN W | 1738 | §103 | Final Rejection | 12d | Pending | Apr 12, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSIDADE FEDERAL DO RIO DE JANEIRO has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Charanjit Aulakh has the most, with 1 of UNIVERSIDADE FEDERAL DO RIO DE JANEIRO's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
